Johnson & Johnson - stock earnings
JNJ Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| Oct. 18, 2022, 8:30 a.m. | 22.5 billion | 23.5 billion | 24.1 billion |
JNJ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020Q3 | 3.6 billion USD | 21.1 billion USD |
| 2021Q1 | 1.7 billion USD | 22.5 billion USD |
| 2021Q2 | 6.2 billion USD | 22.3 billion USD |
| 2021Q3 | 6.3 billion USD | 23.3 billion USD |
| 2021Q4 | 3.7 billion USD | 23.3 billion USD |
| 2022Q1 | 4.7 billion USD | 24.8 billion USD |
| 2022Q2 | 5.1 billion USD | 23.4 billion USD |
| 2022Q3 | 4.8 billion USD | 24.0 billion USD |
JNJ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2017 | 1.3 billion USD | 76.5 billion USD |
| 2018 | 15.3 billion USD | 81.6 billion USD |
| 2019 | 15.1 billion USD | 82.1 billion USD |
| 2021 | 14.7 billion USD | 82.6 billion USD |
| 2022 | 20.9 billion USD | 93.8 billion USD |
JNJ
List: Champions
Price: 166.72USD
Dividend Yield: 2.44%
Forward Dividend Yield: 2.71%
Payout Ratio: 43.46%
Dividend Per Share: 4.52 USD
Earnings Per Share: 10.40 USD
P/E Ratio: 29.52
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers—General
Volume: 5.7 million
Ebitda: 2.9 billionMarket Capitalization: 440.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 61
DGR3: 5.78%
DGR5: 5.87%
DGR10: 6.42%
DGR20: 9.43%